NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
Back to search
Official data from USPTO
J&J
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
10/22/2025
Trademark type
Combined
Nice classes
16, 41, 44
Filing date
09/14/2023
Registration date
10/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/05/2024
First use in commerce
06/05/2024
Drawing code
5
Owner type
03
Owner location
New Brunswick, NJ
Examiner
JANSON,ANDREW KYLE
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an initial "J" followed by an ampersand symbol and an initial "J".
Holders and representatives
Holders
Johnson & Johnson
Representatives
David McDonald JOHNSON & JOHNSON
Technical classification
Nice Classes
Class 16Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed matterarticlesbrochurespamphletsnewsletters containing information in the fields of healthwellnessthe development and use of pharmaceuticalsmedicaments and medical products
Class 41
Educational servicesproviding classesseminarsworkshopspresentationswebinars and conferences to the public and to professionals on the subjects of all aspects of healthpersonal carenutritionwellnessthe development and use of pharmaceuticalsmedicaments and medical products
Class 44
Medical services and health care; provision of medical information; providing medical and healthcare information to patients and healthcare professionals concerning pharmaceutical productsmedical devicesmedical diseases and disorders and related treatments; gene and stem cell therapy medical treatment services
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/02/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/02/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/02/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
10/02/2025
EX1G
SOU EXTENSION 1 GRANTED
10/02/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/03/2025
IUAF
USE AMENDMENT FILED
04/16/2025
DRRR
DIVISIONAL REQUEST RECEIVED
04/16/2025
EXT1
SOU EXTENSION 1 FILED
04/16/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/16/2025
EISU
TEAS STATEMENT OF USE RECEIVED
04/16/2025
EEXT
SOU TEAS EXTENSION RECEIVED
04/16/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/22/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/27/2024
PUBO
PUBLISHED FOR OPPOSITION
08/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
07/18/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/18/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
07/18/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/26/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/26/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/03/2024
GNRT
NON-FINAL ACTION E-MAILED
04/03/2024
CNRT
NON-FINAL ACTION WRITTEN
04/03/2024
DOCK
ASSIGNED TO EXAMINER
04/03/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/03/2023
NWAP
NEW APPLICATION ENTERED
09/18/2023
Continuous trademark protection
Get notified about every new filing that threatens J&J or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.